Tuhura Biosciences earnings were -$27.3M for the trailing 12 months ending Mar 31, 2025, with -99.4% growth year over year. The latest HURA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$6.7M, down 58.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HURA reported annual earnings of -$22.6M, with -22.7% growth.
HURA past earnings growth
How has HURA's earnings growth performed historically?
What were Tuhura Biosciences's earnings last quarter?
Tuhura Biosciences (NASDAQ: HURA) reported Q1 2025 earnings per share (EPS) of -$0.15, up 62.5% year over year. Total HURA earnings for the quarter were -$6.67 million. In the same quarter last year, Tuhura Biosciences's earnings per share (EPS) was -$0.40.
As of the last Tuhura Biosciences earnings report, Tuhura Biosciences is currently losing money. Tuhura Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$26.34 million, a 14.76% decrease year over year.
What was HURA's earnings growth in the past year?
As of Tuhura Biosciences's earnings date in Q2 2025, Tuhura Biosciences's earnings has grown -99.4% year over year. This is 110.93 percentage points lower than the US Biotechnology industry earnings growth rate of 11.53%. HURA earnings in the past year totalled -$27.30 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.